AU2002316237A1 - Use of the parathroid hormone-2 (pth2) receptor to screen for agents to treat pain - Google Patents

Use of the parathroid hormone-2 (pth2) receptor to screen for agents to treat pain

Info

Publication number
AU2002316237A1
AU2002316237A1 AU2002316237A AU2002316237A AU2002316237A1 AU 2002316237 A1 AU2002316237 A1 AU 2002316237A1 AU 2002316237 A AU2002316237 A AU 2002316237A AU 2002316237 A AU2002316237 A AU 2002316237A AU 2002316237 A1 AU2002316237 A1 AU 2002316237A1
Authority
AU
Australia
Prior art keywords
pth2
receptor
agents
screen
treat pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002316237A
Inventor
Ted Usdin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOVERNMENT OF United States, HEALT, Secretary of, Department of
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2002316237A1 publication Critical patent/AU2002316237A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
AU2002316237A 2001-06-13 2002-06-12 Use of the parathroid hormone-2 (pth2) receptor to screen for agents to treat pain Abandoned AU2002316237A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29795901P 2001-06-13 2001-06-13
US60/297,959 2001-06-13
PCT/US2002/018771 WO2002100349A2 (en) 2001-06-13 2002-06-12 Use of the parathroid hormone-2 (pth2) receptor to screen for agents to treat pain

Publications (1)

Publication Number Publication Date
AU2002316237A1 true AU2002316237A1 (en) 2002-12-23

Family

ID=23148425

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002316237A Abandoned AU2002316237A1 (en) 2001-06-13 2002-06-12 Use of the parathroid hormone-2 (pth2) receptor to screen for agents to treat pain

Country Status (2)

Country Link
AU (1) AU2002316237A1 (en)
WO (1) WO2002100349A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1670451A4 (en) 2003-09-11 2009-10-21 Xenoport Inc Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
SG146643A1 (en) 2003-09-17 2008-10-30 Xenoport Inc Treating or preventing restless legs syndrome using prodrugs of gaba analogs
BRPI0517227B8 (en) 2004-11-04 2021-05-25 Xenoport Inc 1-{[alpha-isobutanoyloxyethoxy)carbonyl]amino methyl}-1-acetic acid extended-release tablet, and use of the tablet

Also Published As

Publication number Publication date
WO2002100349A2 (en) 2002-12-19
WO2002100349A3 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
EP1425277B8 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
AU2002258565A1 (en) Device for surface stimulation of acupuncture points
AU2002340139A1 (en) Inhibitors of the egf receptor for the treatment of thyroid cancer
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2003295336A1 (en) Use of etodoclac to treat hyperplasia
AU2001271706A1 (en) Use of substituted indole compounds for treating breast disorders
AU2002322481A1 (en) Use of r-nsaid compounds for anti-hiv treatment
MXPA03007653A (en) Use of lp82 to treat hematopoietic disorders.
AU2002362505A1 (en) Compression sleeve for treatment of the extremities
AU2002316237A1 (en) Use of the parathroid hormone-2 (pth2) receptor to screen for agents to treat pain
AU2001248971A1 (en) Use of npy y1 receptor agonists in the treatment of pain conditions
ZA200505400B (en) The use of estrogen receptor alpha modulators for the treatment of multiple sclerosis
AU2003264297A1 (en) Use of vanilloid receptor antagonists for the treatment of pain
AU2002304883A1 (en) Device for the treatment of tumours
AU2002352471A1 (en) Improvements relating to floor treatment apparatus
AU2002315522A1 (en) Receptor agonists useful for the treatment of pain
AU2683500A (en) Compositions for the treatment of pain
AU2000272704A1 (en) Use of compounds for the treatment of obesity
HUP0303518A3 (en) Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
HUP0400007A2 (en) Use of an alkanoyl-l-carnitine for the preparation of pharmaceutical composition to treat anhedonia
AU2003213349A1 (en) Therapeutic agent for pain
AU2001261023A1 (en) Use of an ampa receptor potentiator for the treatment of obesity
EP1451308A4 (en) Therapeutic use of aziridino compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase